Trupanion (NASDAQ:TRUP) Issues Earnings Results

Trupanion (NASDAQ:TRUP) issued its quarterly earnings results on Wednesday. The financial services provider reported $0.03 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.06) by $0.09, Briefing.com reports. Trupanion had a negative net margin of 1.57% and a negative return on equity of 6.29%. The company had revenue of $327.50 million during the quarter, compared to analyst estimates of $321.79 million. During the same quarter last year, the business posted ($0.10) EPS. Trupanion’s quarterly revenue was up 14.6% compared to the same quarter last year. Trupanion updated its Q4 2024 guidance to EPS and its FY 2024 guidance to EPS.

Trupanion Stock Performance

Trupanion stock opened at $55.12 on Thursday. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.42. Trupanion has a 1-year low of $19.14 and a 1-year high of $55.74. The firm has a market capitalization of $2.32 billion, a PE ratio of -86.13 and a beta of 1.73. The firm’s 50 day simple moving average is $46.73 and its 200 day simple moving average is $35.87.

Wall Street Analyst Weigh In

A number of analysts have issued reports on TRUP shares. Piper Sandler raised their target price on Trupanion from $38.00 to $45.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 2nd. William Blair started coverage on Trupanion in a research note on Friday, July 19th. They issued an “outperform” rating on the stock. Bank of America increased their target price on shares of Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a research report on Friday, September 20th. Stifel Nicolaus lifted their target price on shares of Trupanion from $30.00 to $40.00 and gave the stock a “hold” rating in a research note on Monday, September 23rd. Finally, Evercore ISI upgraded shares of Trupanion to a “strong-buy” rating in a research note on Friday, August 9th. Four research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $41.83.

Insider Activity at Trupanion

In other Trupanion news, CEO Margaret Tooth sold 7,500 shares of the company’s stock in a transaction dated Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the transaction, the chief executive officer now directly owns 99,984 shares in the company, valued at $4,647,256.32. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CFO Fawwad Qureshi sold 640 shares of the stock in a transaction on Friday, August 16th. The stock was sold at an average price of $43.12, for a total value of $27,596.80. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Margaret Tooth sold 7,500 shares of Trupanion stock in a transaction dated Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the sale, the chief executive officer now directly owns 99,984 shares of the company’s stock, valued at approximately $4,647,256.32. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 8,764 shares of company stock valued at $405,238. Company insiders own 5.50% of the company’s stock.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.